Location History:
- Silver Spring, MD (US) (1998 - 2009)
- Potomac, MD (US) (2012 - 2015)
- Chevy Chase, MD (US) (2018 - 2024)
Company Filing History:
20 out of 3,435 
1 out of 45 
1 out of 13 Years Active: 1998-2025
Title: The Innovative Contributions of Paul F Robbins in Cancer Research
Introduction: Paul F Robbins, based in Chevy Chase, MD, is a distinguished inventor known for his significant contributions to the field of cancer research and immunotherapy. With a remarkable portfolio of 18 patents, Robbins has dedicated his career to developing innovative methods and compositions that enhance cancer detection and treatment.
Latest Patents: Among his latest patents are groundbreaking inventions that address critical challenges in cancer therapy. One notable patent involves HLA class II-restricted T cell receptors targeting mutated Kirsten rat sarcoma viral oncogene homolog (KRAS). This invention encompasses a purified T cell receptor with specificity for mutated KRAS presented by human leukocyte antigen Class II molecules. It also covers related polypeptides, proteins, nucleic acids, recombinant expression vectors, host cells, and pharmaceutical compositions. Additionally, methods for detecting cancer in mammals and strategies for treating or preventing cancer are highlighted.
Another significant patent introduces methods for isolating T cells that possess antigenic specificity for cancer-specific mutations. This process includes identifying cancer-specific mutations in a patient’s nucleic acid, inducing autologous antigen-presenting cells (APCs) to display the mutated sequences, and co-culturing with the patient’s T cells for selection. These methods pave the way for preparing cell populations and pharmaceutical compositions aimed at treating or preventing cancer.
Career Highlights: Throughout his career, Robbins has represented the United States of America through the Secretary of the Department of Health and Human Services and has worked with Immunocore Limited, where he has pushed the boundaries of cancer immunotherapy research. His work has not only contributed to scientific advancements but has also opened new avenues for therapeutic applications.
Collaborations: Paul F Robbins has collaborated with esteemed colleagues such as Steven A Rosenberg and Yong-Chen Lu. Their joint efforts have significantly influenced the landscape of cancer research and have fostered innovative approaches to therapy and detection techniques.
Conclusion: Paul F Robbins's innovative spirit and dedication to improving cancer treatment have established him as a key figure in the field. His 18 patents reflect a commitment to advancing medical science and providing hope for those battling cancer, making him a prominent inventor in this vital area of healthcare.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.